Healthcare provider profile · identity verified

Sonia Kohli, MD

Internal Medicine · SLEEPY HOLLOW, NY · NPI 1982924353

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	279	118
Losartan Potassium	Losartan Potassium	178	66
Levothyroxine Sodium	Levothyroxine Sodium	171	60
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	128	31
Hydrochlorothiazide	Hydrochlorothiazide	123	51
Atenolol	Atenolol	121	48
Lisinopril	Lisinopril	119	50
Amlodipine Besylate	Amlodipine Besylate	118	55
Fluticasone Propionate	Fluticasone Propionate	86	37
Albuterol Sulfate Hfa	Albuterol Sulfate	69	46
Tamsulosin Hcl	Tamsulosin Hcl	69	30
Pantoprazole Sodium	Pantoprazole Sodium	68	28
Famotidine	Famotidine	67	29
Gabapentin	Gabapentin	66	22
Omeprazole	Omeprazole	60	20
Trazodone Hcl	Trazodone Hcl	58	21
Jardiance	Empagliflozin	55	21
Alvesco	Ciclesonide	54	36
Metformin Hcl Er	Metformin Hcl	54	23
Simvastatin	Simvastatin	54	24
Metformin Hcl	Metformin Hcl	51	18
Alendronate Sodium	Alendronate Sodium	48	18
Furosemide	Furosemide	48	22
Metoprolol Tartrate	Metoprolol Tartrate	46	22
Ozempic	Semaglutide	44	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	24
Ibuprofen	Ibuprofen	42	20
Metoprolol Succinate	Metoprolol Succinate	42	15
Prednisone	Prednisone	38	26
Glipizide	Glipizide	37	15
Ipratropium Bromide	Ipratropium Bromide	36	13
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Allopurinol	Allopurinol	34	15
Sertraline Hcl	Sertraline Hcl	33	13
Sumatriptan Succinate	Sumatriptan Succinate	33	suppressed
Baclofen	Baclofen	32	suppressed
Lovastatin	Lovastatin	32	14
Promethazine Hcl	Promethazine Hcl	29	suppressed
Amoxicillin	Amoxicillin	27	18
Propranolol Hcl	Propranolol Hcl	26	suppressed
Temazepam	Temazepam	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	14
Pregabalin	Pregabalin	24	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	24	11
Azithromycin	Azithromycin	23	11
Pravastatin Sodium	Pravastatin Sodium	23	11
Tramadol Hcl	Tramadol Hcl	23	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Hydrocortisone	Hydrocortisone	20	11
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	14
Humulin N Kwikpen	Insulin Nph Human Isophane	17	suppressed
Meloxicam	Meloxicam	17	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	17
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Carvedilol	Carvedilol	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	15	suppressed
Cholestyramine	Cholestyramine (With Sugar)	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Naproxen	Naproxen	15	suppressed
Colchicine	Colchicine	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Butalbital-Acetaminophen	Butalbital/Acetaminophen	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	11	11
Diazepam	Diazepam	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error